Development and Validation of a Nomogram to Predict Recurrence of Primary Hyperhidrosis after CT-guided Percutaneous Radiofrequency Sympathectomy

医学 列线图 危险系数 置信区间 多汗症 回顾性队列研究 经皮 比例危险模型 放射科 外科 内科学
作者
Zixin Han,Rui Min,Zhiqiang Zhang,Jiayi Tang,Longsheng Xu,Ming Yao
出处
期刊:Journal of Vascular and Interventional Radiology [Elsevier]
卷期号:34 (11): 1892-1900.e4 被引量:1
标识
DOI:10.1016/j.jvir.2023.07.030
摘要

To evaluate the recurrence rate of primary hyperhidrosis (PH) after computed tomography (CT)-guided radiofrequency sympathectomy (RFS) and identify risk factors associated with recurrence.A total of 290 patients with PH who underwent CT-guided RFS were included in this retrospective cohort study. The electronic medical record was reviewed for patients' information and procedural parameters. Follow-ups were conducted for recurrence rate, and Hyperhidrosis Disease Severity Scale was used to assess presence or absence of recurrence. Stepwise regression and the least absolute shrinkage and selection operator regression algorithms were used for feature selection.The recurrence rate 1 year after procedure was 17.6%. Male (hazard ratio [HR], 2.35; 95% confidence interval [CI], 1.08-5.15), low postoperative palm or foot temperature (HR, 0.77; 95% CI, 0.60-0.98), high postoperative heart rate (HR, 1.06; 95% CI, 1.02-1.10), low preoperative and postoperative hospital anxiety and depression score difference (HR, 0.59; 95% CI, 0.43-0.80), and the absence of compensatory hyperhidrosis immediately after procedure (HR, 0.46; 95% CI, 0.22-0.98) were established as independent factors affecting prognosis. A nomogram was built accordingly. The C indices of the training and testing sets were 0.773 and 0.659, respectively.Follow-up results showed that the recurrence rate of PH treated with CT-guided RFS was low. This study constructed and validated a nomogram to predict the recurrence of PH 1 year after CT-guided RFS, which is convenient for interventionalists to evaluate accurately the prognosis of patients postoperatively and to identify high-risk patients who need more active treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
科研通AI5应助stt采纳,获得10
1秒前
sunzhiyu233发布了新的文献求助10
2秒前
2秒前
缓缓地安静关注了科研通微信公众号
3秒前
3秒前
送外卖了完成签到,获得积分10
3秒前
Blue_Pig完成签到,获得积分10
3秒前
Orange应助feng采纳,获得10
3秒前
4秒前
考虑考虑发布了新的文献求助10
4秒前
毛慢慢发布了新的文献求助10
4秒前
阿宝发布了新的文献求助10
4秒前
深情安青应助通~采纳,获得10
4秒前
Percy完成签到 ,获得积分10
4秒前
xiuxiu_27发布了新的文献求助10
5秒前
顾矜应助千里采纳,获得10
5秒前
神勇的雅香应助妮儿采纳,获得10
5秒前
qi完成签到,获得积分10
6秒前
哒哒发布了新的文献求助10
6秒前
知行完成签到,获得积分10
6秒前
6秒前
7秒前
Yenom发布了新的文献求助10
7秒前
8秒前
滴滴发布了新的文献求助10
9秒前
心灵美发卡完成签到,获得积分10
9秒前
科目三应助浩浩大人采纳,获得10
10秒前
考虑考虑完成签到,获得积分10
10秒前
彪壮的刺猬完成签到,获得积分10
11秒前
杏花饼完成签到,获得积分10
11秒前
Ll发布了新的文献求助10
11秒前
11秒前
汉堡包应助啊娴仔采纳,获得10
12秒前
12秒前
珂伟完成签到,获得积分10
12秒前
鲜艳的帅哥完成签到,获得积分10
13秒前
wkjsdsg完成签到,获得积分10
13秒前
大七完成签到 ,获得积分10
13秒前
13秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527699
求助须知:如何正确求助?哪些是违规求助? 3107752
关于积分的说明 9286499
捐赠科研通 2805513
什么是DOI,文献DOI怎么找? 1539954
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709759